Home  >  Products  >  PPAP2A (phosphatidic acid phosphatase type 2A) Blocking Peptide (the N terminal of PPAP2A)(100ug)
PPAP2A (phosphatidic acid phosphatase type 2A) Blocking Peptide (the N terminal of PPAP2A)(100ug)

PPAP2A (phosphatidic acid phosphatase type 2A) Blocking Peptide (the N terminal of PPAP2A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PPAP2A Antibody(ARP42145_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP42145
Size: 100ug
Weight: 32kDa
Gene: 8611
Format: Lyophilized powder
Target: PPAP2A is a member of the phosphatidic acid phosphatase (PAP) family. PAPs convert phosphatidic acid to diacylglycerol, and function in de novo synthesis of glycerolipids as well as in receptor-activated signal transduction mediated by phospholipase D. This protein is an integral membrane glycoprotein, and has been shown to be a surface enzyme that plays an active role in the hydrolysis and uptake of lipids from extracellular space. The expression of PPAP2A is found to be regulated by androgen in a prostatic adenocarcinoma cell line.
Alternative names: LLP1a; LPP1; PAP-2a; PAP2; PAP2a2; PAP2alpha2; PAPalpha1
See Full Product Listings >